Zobrazeno 1 - 10
of 156
pro vyhledávání: '"O'Toole Margot"'
Autor:
Garred, Eileen, Brown, Sue Avery
Publikováno v:
People. 4/15/91, Vol. 35 Issue 14, p51-52. 2p. 4 Black and White Photographs.
Autor:
Carrier, Yijun *, Ma, Hak-Ling, Ramon, Hilda E., Napierata, Lee, Small, Clayton, O'Toole, Margot, Young, Deborah A., Fouser, Lynette A., Nickerson-Nutter, Cheryl, Collins, Mary, Dunussi-Joannopoulos, Kyri, Medley, Quintus G. *
Publikováno v:
In Journal of Investigative Dermatology December 2011 131(12):2428-2437
Autor:
Mukhopadhyay, Somnath, Sypek, Joseph, Tavendale, Roger, Gartner, Ulrike, Winter, John, Li, Wei, Page, Karen, Fleming, Margaret, Brady, Jeff, O'Toole, Margot, Macgregor, Donald F., Goldman, Samuel, Tam, Steve, Abraham, William, Williams, Cara, Miller, Douglas K., Palmer, Colin N.A.
Publikováno v:
In The Journal of Allergy and Clinical Immunology 2010 126(1):70-76
Autor:
Heinz, Lisa C.1, Chubin, Daryl E.1
Publikováno v:
BioScience. Sep88, Vol. 38 Issue 8, p559-561. 3p.
Publikováno v:
The Journal of Infectious Diseases, 1999 Oct 01. 180(4), 940-949.
Externí odkaz:
https://www.jstor.org/stable/30109889
Autor:
Young Deborah, LaVallie Edward R, Allen Scott W, Smith Michael F, Bree Andrea G, Guo Yongjing, Hill Andrew A, Weaver Amy A, Jain Sadhana, Arai Maya, Bloom Laird, Adkins Karissa, O'Toole Margot
Publikováno v:
Journal of Translational Medicine, Vol 8, Iss 1, p 51 (2010)
Abstract Background In preparation for potential clinical development of Ab-01, an antagonistic antibody directed against the IL21R, studies were undertaken to address translational medicine needs that fall into four categories: 1) development of a p
Externí odkaz:
https://doaj.org/article/3b71efee11dd46209e99d844e0374d20
Autor:
Bechard Theresa, Ryan Mark, LaVallie Edward R, Young Deborah, Corcoran Christopher, Immermann Frederick W, Ramsey Renee C, Hill Andrew A, Guo Yongjing, Pfeifer Richard, Warner Garvin, Bologna Marcia, Bloom Laird, O'Toole Margot
Publikováno v:
Journal of Translational Medicine, Vol 8, Iss 1, p 50 (2010)
Abstract Background Selective neutralization of the IL21/IL21R signaling pathway is a promising approach for the treatment of a variety of autoimmune diseases. Ab-01 is a human neutralizing anti-IL21R antibody. In order to ensure that the activities
Externí odkaz:
https://doaj.org/article/d81a46fb9576409bb1516323716aa216
Autor:
Spaulding Vikki, Ma Margery, Ryan Mark, Bree Andrea, Szklut Pamela, Allen Scott, Vugmeyster Yulia, Young Deborah, Guay Heath, Bloom Laird, Leach Michael W, O'Toole Margot, Adkins Karissa
Publikováno v:
Journal of Translational Medicine, Vol 8, Iss 1, p 41 (2010)
Abstract Background Anti-IL-21R antibodies are potential therapeutics for the treatment of autoimmune diseases. This study evaluated correlations between the pharmacodynamic (PD) activity, pharmacokinetics, and anti-product antibody responses of huma
Externí odkaz:
https://doaj.org/article/35d31fdcc02545418bf857e6cc8413e7